{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:32:37Z","timestamp":1793410357278,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jacbts.2024.02.017","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T14:52:06Z","timestamp":1713365526000},"page":"1041-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Reassessing the Mechanisms of\u00a0PLN-R14del Cardiomyopathy"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7658-9291","authenticated-orcid":false,"given":"Nienke M.","family":"Stege","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Makarewich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman H.W.","family":"Sillj\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jacbts.2024.02.017_bib1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12471-013-0401-3","article-title":"Recurrent and founder mutations in the Netherlands\u2013phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy","volume":"21","author":"van der Zwaag","year":"2013","journal-title":"Neth Heart J"},{"issue":"5","key":"10.1016\/j.jacbts.2024.02.017_bib2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A\u00a0mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.jacbts.2024.02.017_bib3","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.jacbts.2024.02.017_bib4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.amjcard.2013.06.017","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers","volume":"112","author":"Groeneweg","year":"2013","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.jacbts.2024.02.017_bib5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCRESAHA.123.323304","article-title":"DWORF extends life span in a PLN-R14del cardiomyopathy mouse model by reducing abnormal sarcoplasmic reticulum clusters","volume":"133","author":"Stege","year":"2023","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.jacbts.2024.02.017_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12471-018-1211-4","article-title":"Prevalence and cardiac phenotype of patients with a phospholamban mutation","volume":"27","author":"Hof","year":"2019","journal-title":"Neth Heart J"},{"issue":"7","key":"10.1016\/j.jacbts.2024.02.017_bib7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jacc.2006.07.016","article-title":"Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy","volume":"48","author":"DeWitt","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacbts.2024.02.017_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12471-019-1247-0","article-title":"Phospholamban cardiomyopathy: a Canadian perspective on a unique population","volume":"27","author":"Cheung","year":"2019","journal-title":"Neth Heart J"},{"issue":"1","key":"10.1016\/j.jacbts.2024.02.017_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73359-8","article-title":"The phenotypic characteristic observed by cardiac magnetic resonance in a PLN-R14del family","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.jacbts.2024.02.017_bib10","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2169\/internalmedicine.8594-21","article-title":"Phospholamban p.Arg14del cardiomyopathy: a Japanese case series","volume":"61","author":"Tabata","year":"2022","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.jacbts.2024.02.017_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12471-021-01584-5","article-title":"Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)","volume":"30","author":"te Rijdt","year":"2022","journal-title":"Neth Heart J"},{"issue":"4","key":"10.1016\/j.jacbts.2024.02.017_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.recesp.2014.11.017","article-title":"Phospholamban p.arg14del mutation in a Spanish family with arrhythmogenic cardiomyopathy: evidence for a European founder mutation","volume":"68","author":"L\u00f3pez-Ayala","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"4","key":"10.1016\/j.jacbts.2024.02.017_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.hrthm.2009.01.016","article-title":"Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes","volume":"6","author":"Posch","year":"2009","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.jacbts.2024.02.017_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ Res"},{"issue":"6868","key":"10.1016\/j.jacbts.2024.02.017_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.jacbts.2024.02.017_bib16","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1016\/S0021-9258(18)69309-3","article-title":"Sequence analysis of phospholamban: identification of phosphorylation sites and two major structural domains","volume":"261","author":"Simmerman","year":"1986","journal-title":"J\u00a0Biol Chem"},{"issue":"22","key":"10.1016\/j.jacbts.2024.02.017_bib17","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1016\/S0021-9258(18)51579-9","article-title":"Expression and site-specific mutagenesis of phospholamban: studies of residues involved in phosphorylation and pentamer formation","volume":"264","author":"Fujii","year":"1989","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.jacbts.2024.02.017_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.yjmcc.2011.11.012","article-title":"The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na\/K-ATPase","volume":"52","author":"Haghighi","year":"2012","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.jacbts.2024.02.017_bib19","first-page":"502","article-title":"Impaired right ventricular calcium cycling is an early risk factor in R14del-phospholamban arrhythmias","volume":"11","author":"Haghighi","year":"2021","journal-title":"J\u00a0Pers Med"},{"issue":"3","key":"10.1016\/j.jacbts.2024.02.017_bib20","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3390\/ijms24032675","article-title":"Myofilament alterations associated with human R14del-phospholamban cardiomyopathy","volume":"24","author":"Kumar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2024.02.017_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155344","article-title":"Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts","volume":"138","author":"Rogalska","year":"2023","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.jacbts.2024.02.017_bib22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/CIRCULATIONAHA.105.583351","article-title":"The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling","volume":"113","author":"Zhao","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacbts.2024.02.017_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14082","article-title":"Early consequences of the phospholamban mutation PLN-R14del+\/- in a transgenic mouse model","volume":"240","author":"Maniezzi","year":"2024","journal-title":"Acta Physiol (Oxf)"},{"issue":"24","key":"10.1016\/j.jacbts.2024.02.017_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413500","article-title":"Characterization of the PLN p.Arg14del mutation in human induced pluripotent stem cell-derived cardiomyocytes","volume":"22","author":"Badone","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jacbts.2024.02.017_bib25","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1038\/s41467-021-27461-8","article-title":"Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy","volume":"12","author":"Kamel","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.jacbts.2024.02.017_bib26","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1074\/jbc.M114.585604","article-title":"Regulation of the sarcoplasmic reticulum calcium pump by divergent phospholamban isoforms in zebrafish","volume":"290","author":"Gorski","year":"2015","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.jacbts.2024.02.017_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013074","article-title":"Impairment of the ER\/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation","volume":"13","author":"Cuello","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"20","key":"10.1016\/j.jacbts.2024.02.017_bib28","doi-asserted-by":"crossref","first-page":"16521","DOI":"10.1074\/jbc.M112.360859","article-title":"Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy","volume":"287","author":"Ceholski","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.jacbts.2024.02.017_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106746","article-title":"Comparison of the structure and function of phospholamban and the arginine-14 deficient mutant associated with dilated cardiomyopathy","volume":"9","author":"Hughes","year":"2014","journal-title":"PLoS One"},{"issue":"1 Pt 1","key":"10.1016\/j.jacbts.2024.02.017_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbamem.2014.09.007","article-title":"Effects of naturally occurring arginine 14 deletion on phospholamban conformational dynamics and membrane interactions","volume":"1848","author":"Vostrikov","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"49","key":"10.1016\/j.jacbts.2024.02.017_bib31","doi-asserted-by":"crossref","first-page":"38938","DOI":"10.1074\/jbc.M004079200","article-title":"A\u00a0single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists","volume":"275","author":"Chu","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.jacbts.2024.02.017_bib32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/cvr\/cvad037","article-title":"Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation","volume":"119","author":"Funk","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.jacbts.2024.02.017_bib33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1172\/JCI17892","article-title":"Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human","volume":"111","author":"Haghighi","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.jacbts.2024.02.017_bib34","first-page":"41","article-title":"Phospholamban p.Leu39\u2217 cardiomyopathy compared with other sarcomeric cardiomyopathies: age-matched patient cohorts and literature review","volume":"11","author":"Afana","year":"2024","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"issue":"5611","key":"10.1016\/j.jacbts.2024.02.017_bib35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jacbts.2024.02.017_bib36","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1073\/pnas.1013987108","article-title":"Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A","volume":"108","author":"Ha","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2024.02.017_bib37","doi-asserted-by":"crossref","unstructured":"Cleary SR, Teng ACT, Kongmeneck AD, et\u00a0al. Dilated cardiomyopathy variant R14del increases phospholamban pentamer stability, blunting dynamic regulation of cardiac calcium handling. Preprint. Posted online May 28, 2023. bioRxiv 2023:2023.05.26.542463. https:\/\/doi.org\/10.1101\/2023.05.26.542463","DOI":"10.1101\/2023.05.26.542463"},{"issue":"13","key":"10.1016\/j.jacbts.2024.02.017_bib38","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1113\/JP281579","article-title":"Increasing SERCA function promotes initiation of calcium sparks and breakup of calcium waves","volume":"599","author":"Sato","year":"2021","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacbts.2024.02.017_bib39","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jacbts.2024.02.017_bib40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/his.12963","article-title":"Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation","volume":"69","author":"te Rijdt","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.jacbts.2024.02.017_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.carpath.2017.05.004","article-title":"Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy","volume":"30","author":"te Rijdt","year":"2017","journal-title":"Cardiovasc Pathol"},{"issue":"13","key":"10.1016\/j.jacbts.2024.02.017_bib42","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.3390\/ijms23136947","article-title":"Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca2+ Handling and Arrhythmogenesis","volume":"23","author":"Vafiadaki","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jacbts.2024.02.017_bib43","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1038\/s41598-020-66656-9","article-title":"The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy","volume":"10","author":"Eijgenraam","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jacbts.2024.02.017_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008532","article-title":"Protein aggregation is an early manifestation of phospholamban p.(Arg14del)-related cardiomyopathy: development of PLN-R14del-related cardiomyopathy","volume":"14","author":"Eijgenraam","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.jacbts.2024.02.017_bib45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/CIRCULATIONAHA.120.049844","article-title":"Unfolded protein response as a compensatory mechanism and potential therapeutic target in PLN R14del cardiomyopathy","volume":"144","author":"Feyen","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacbts.2024.02.017_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ehjci\/jey047","article-title":"Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging","volume":"20","author":"Te Rijdt","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jacbts.2024.02.017_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11897-022-00558-x","article-title":"Review: precision medicine approaches for genetic cardiomyopathy: targeting phospholamban R14del","volume":"19","author":"Deiman","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacbts.2024.02.017_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1162205","article-title":"Phospholamban R14del disease: the past, the present and the future","volume":"10","author":"Vafiadaki","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"15","key":"10.1016\/j.jacbts.2024.02.017_bib49","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1093\/cvr\/cvac021","article-title":"Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact","volume":"118","author":"Dave","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.jacbts.2024.02.017_bib50","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1038\/s41467-021-25439-0","article-title":"Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy","volume":"12","author":"Grote Beverborg","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jacbts.2024.02.017_bib51","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/ijms23052427","article-title":"Antisense therapy attenuates phospholamban p.(Arg14del) cardiomyopathy in mice and reverses protein aggregation","volume":"23","author":"Eijgenraam","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jacbts.2024.02.017_bib52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/CIRCULATIONAHA.123.064513","article-title":"SERCA2a protein levels are unaltered in human heart failure","volume":"148","author":"Ragone","year":"2023","journal-title":"Circulation"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X24000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X24000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T15:20:49Z","timestamp":1724685649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X24000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2452302X24000962"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2024.02.017","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reassessing the Mechanisms of\u00a0PLN-R14del Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2024.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}